Invasive salmonella infections and HIV in northern tanzania

Clinical Infectious Diseases

Volumn 52, Issue 3, 2011, Pages 349-351

  Levine, Myron M ^a   Farag, Tamer H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL STRAIN; BACTERIUM ISOLATION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; TANZANIA; TYPHOID FEVER;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTEREMIA; HIV INFECTIONS; HUMANS; PREVALENCE; SALMONELLA TYPHI; TANZANIA; TYPHOID FEVER; YOUNG ADULT;

EID: 79951844268     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq109     Document Type: Editorial

References (27)

1. Mweu E, English M. Typhoid fever in children in Africa. Trop Med Int Health 2008;13:532-40. (Pubitemid 351533604)
2. Keddy KH, Sooka A, Ismail H, et al. Molecular epidemiological investigation of a typhoid fever outbreak in South Africa, 2005: The relationship to a previous epidemic in 1993. Epidemiol Infect 2010;28:1-7.
3. Huckstep RL. Typhoid fever and other Salmonella infections. Edinburgh, UK: e & S Livingstone; 1962.
4. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005;352:39-47. (Pubitemid 40075679)
5. Enwere G, Biney E, Cheung YB, et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 2006;25:700-5. (Pubitemid 44162127)
6. Ikumapayi UN, Antonio M, Sonne-Hansen J, et al. Molecular epidemiology of communityacquired invasive non-typhoidal Salmonella among children aged 2-29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri. J Med Microbiol 2007;56:1479-84. (Pubitemid 350175073)
7. Tennant SM, Diallo S, Levy H, et al. Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Negl Trop Dis 2010;4: e621.
8. Sigaúque B, Roca A, Mandomando I, et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J 2009;28:108-13.
9. Mandomando I, Macete E, Sigaúque B, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health 2009;14:1467-74.
10. Walsh AL, Phiri AJ, Graham SM, Molyneux EM, Molyneux ME. Bacteremia in febrile Malawian children: Clinical microbiologic features. Pediatr Infect Dis J 2000;19:312-8. (Pubitemid 30213070)
11. Gordon MA. Salmonella infections in immunocompromised adults. J Infect 2008;56:413-22.
12. Gordon MA, Graham SM. Invasive salmonellosis in Malawi. J Infect Dev Ctries 2008;2:438-42.
13. Gotuzzo E, Frisancho O, Sanchez J, et al. Association between the acquired immunodeficiency syndrome infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 1991;151:381-2.
14. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: Examples from the AIDS literature. Ann Intern Med 1996;124:999-1005.
15. Sztein MB, Tanner MK, Polotsky Y, Orenstein JM, Levine MM. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol 1995;155:3987-93.
16. Sztein MB. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. Clin Infect Dis 2007;45: S15-S19. (Pubitemid 47036019)
17. Sztein MB, Wasserman SS, Tacket CO, et al. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 1994;170:1508-17. (Pubitemid 24369911)
18. Hoffman S, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicoltreated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984;310:82-8. (Pubitemid 14214864)
19. Woodward TE, Hall HE, Dias-Rivera R, Hightower JA, Martinez E, Parker RT. Treatment of typhoid fever. II: Control of clinical manifestations with cortisone. Ann Intern Med 1951;34:10-9.
20. Snyder MJ, Hornick RB, McCrumb FR Jr, Morse LJ, Woodward TE. Asymptomatic typhoidal bacteremia in volunteers. Antimicrob Agents Chemother (Bethesda) 1963;161:604-7.
21. Gordon MA, Kankwatira AM, Mwafulirwa G, et al. Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: An emerging disease pathogenesis. Clin Infect Dis 2010;50:953-62.
22. Kingsley RA, Msefula CL, Thomson NR, et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 2009;19:2279-87.
23. Jones TF, Ingram LA, Cieslak PR, et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008;198:109-14. (Pubitemid 351920297)
24. Fierer J, Guiney DG. Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest 2001;107:775-80. (Pubitemid 32274025)
25. Santos RL, Raffatellu M, Bevins CL, et al. Life in the inflamed intestine, Salmonella style. Trends Microbiol 2009;17:498-506.
26. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, Baumler AJ. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 2005;73:3367-74. (Pubitemid 40745878)
27. Tran QT, Gomez G, Khare S, et al. The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect Immun 2010;78:527-35.